AUSTIN, Texas — GLP-1 drugs like Ozempic, Wegovy, and Mounjaro, primarily known for their diabetes treatment, are increasingly recognized for their role in weight loss. This trend may significantly affect dairy consumption. Users of these medications tend to eat less overall, making the nutritional value of their food choices more critical. Dietitians recommend that GLP-1 users prioritize protein intake to help maintain muscle mass during weight loss, positioning dairy products favorably.
Read More
Current dairy items such as Greek yogurt, cottage cheese, high-protein milk, and ready-to-drink protein shakes are drawing consumer interest due to their high protein content without requiring large meals. Additionally, there’s a growing market for whole milk and full-fat dairy as consumers shift focus from low-fat options to nutrition, protein, and flavor.
While GLP-1 medications may not directly drive dairy sales, they add momentum to an existing consumer preference for protein-rich foods. Dairy not only provides protein but also contains 13 essential nutrients vital for bone health, energy metabolism, and overall wellness.
Beyond traditional grocery items, the demand for whey protein is increasing. Manufacturers are incorporating whey into an array of products, including protein drinks and bars, leading to significant investments in facilities that produce high-value whey protein concentrates and isolates. This shift emphasizes the importance of milk's individual components, changing the conversation around dairy value from volume sales to the nutritional components within.
At the farm level, there is no immediate need for dairy producers to alter their herds based solely on the increasing use of GLP-1 drugs. However, market trends show processors investing in high-protein dairy products, which suggests a potential rise in the importance of protein in the dairy market. Retailers are also focusing on protein-heavy foods, reflecting a consumer readiness to pay for more nutritious, convenient options.
Despite some uncertainty regarding the long-term impact of GLP-1 drugs on food consumption, including their potential to negatively affect less nutrient-dense products, the broader trend toward protein-rich diets is likely to persist. For Texas dairy producers, the implications are significant; the state is experiencing growth in milk production and investment in processing capabilities to enhance the value derived from milk’s protein content. While GLP-1 medications are not the sole factor driving protein demand, they may be hastening an ongoing industry shift toward providing more nutritious and protein-rich dairy options. — Darren Turley, Executive Director, Texas Association of Dairymen.